The design and development of selective, photoactivated drugs for sterilization of blood products

Drugs of the Future

Volumn 22, Issue 2, 1997, Pages 159-171

  Goodrich, Raymond P ^a,c   Platz, Matthew S ^b  

^a Cryopharm Corporation   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Gambro BCT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 HYDROXY 2 METHYL 4 OXO 1 PYRIDYL)PROPIONIC ACID; ASCORBIC ACID; BLOOD DERIVATIVE; CP 45; CYSTEINE; METHOXSALEN DERIVATIVE; PHOTOSENSITIZING AGENT; PSORALEN DERIVATIVE; UNCLASSIFIED DRUG;

BLOOD; DISEASE TRANSMISSION; DRUG CONTAMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG STERILITY; DRUG TARGETING; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PHOTOACTIVATION; REVIEW; TECHNIQUE;

EID: 0031000909     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.02.400935     Document Type: Review

References (52)

1. Wallace, E.L., Surgenor, D.M., Hao, H.S., An, J., Chapman, R.H., Churchill, W.H. Collection and transfusion of blood and blood components in the United States. Transfusion 1993, 33: 139.
2. Curran, J.W., Lawrence, D.N., Jaffe, H. et. al. Acquired immune deficiency syndrome (AIDS) associated with transfusion. New Engl J Med 1984, 310: 69.
3. Selik, R.M., Ward, J.W., Buehler, J.W. Trends in transfusion-associated acquired immune deficiency syndrome in the United States. Transfusion 1993, 33: 890.
4. Dodd, R.Y. The risk of transfusion transmitted infection. New Engl J Med 1992, 327: 419.
5. Cummings, P.D., Wallace, E.L., Schorr, J.B., Dodd, R.Y. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative. New Engl J Med 1989, 321: 941.
6. Horowitz, M.S., Horowitz, B., Rooks, C., Hilgartner, M.W. Virus safety of solvent/detergent treated antihaemophilic factor concentrate. Lancet 1988, ii: 186.
7. Rees, W.C.H., Friesen, A.D., Janzen, R.G. Validation of large scale column chromatographic process for production of albumin and intravenous immunoglobulin. In: Biotechnology of Plasma Protein. Stoltz, J.F., Rivat, E. (Eds.). Colloque Inserm 1989, 207.
8. Kessel, D. (Ed.). Photodynamic Therapy of Neoplastic Disease, Vol. I and II. CRC Press: Boca Raton 1990.
9. Matthew, J.L., Newman, J.T., Sugandares-Bernal, F. et al. Photodynamic therapy of viral contaminants with potential for blood banking applications. Transfusion 1988, 28: 81.
10. O'Brien, J.M., Montgomery, R.R., Burns, W.H., Goffney, D.K., Sieber, F. Evaluation of merocyanine-540 sensitized photoirradiation as a means to inactivate enveloped viruses in blood products. J Lab Clin Med 1990, 116: 439.
11. Dodd, R.Y., Moroff, G., Wagner, S. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: Comparison of psoralen-ultraviolet A andmerocyanine 540-visible light methods. Transfusion 1991, 31: 483.
12. Rywkin, S., Lenny, L., Goldstein, J., Geactinov, N.E., Margolis-Nunno, H., Horowitz, B. Importance of Type I and Type II mechanisms in the photodynamic inactivation of viruses in blood with aluminum phthalocyanine derivatives. Photochem Photobiol 1992, 56: 463.
13. Lambrecht, B., Mohr, H., Knuver-Hopf, J., Shmitt, H. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 1991, 60: 207.
14. Leonard, J., Rabson, A., Vanderoef, R. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: Inhibition of fusion and syncytia formation. Proc Natl Acad Sci USA 1993, 9: 158.
15. Bradley, R. Bovine spongiforme encephalopathy (BSE). The current situation and research. Eur J Epidemiol 1991, 532: 7.
16. Saenger, W. (Ed.). Principles of Nucleic Acid Structure. Springer-Verlag: New York 1984.
17. Lerman, L.S., Structural considerations in the interaction of DNA and acridines. J Mol Biol 1961, 3: 18.
18. Von Sonntag, C., Hagen, U., Bopp-Schon, A., Schulte-Frohlinde, D. Radiation induced strand breaks in DNA: Chemical and enzymatic analysis of end groups and mechanistic aspects. Adv Radiat Biol 1981, 9: 109.
19. Rabow, L.E., Stubbe, J., Kozarich, J.W. Identification and quantification of the lesion accompanying base release in bleomycin mediated DNA degradation. J Am Chem Soc 1990, 112: 3196.
20. Scaiano, J.C., Stewart, L.C. Phenyl radical kinetics. J Am Chem Soc 1983, 105: 3609.
21. Haselbach, E., Rohmer, Y., Suppan, P. Photodissociation of halonaphthalenes in solution: Comparative photochemistry of 1-iodo, 1-bromo and 1-chloronaphthalenes. Helv Chem Acta 1990, 73: 1.
22. Nagamura, T., Nakayama, T., Hamanoue, K. Participation of the lowest excited singlet states of 9-bromoanthracene and 9, 10-dibromoanthracene for their photochemical debrominations by amine (triethylamine or N,N-dimethylaniline) in acetonitrile. Chem Lett 1991, 2051.
23. Murov, S.L. (Ed.). Handbook of Photochemistry. Marcel Dekker: New York 1973.
24. Freeman, P.K., Jang, J.S., Ramnath, N. The photochemistry of polyhaloarenes. 10. The photochemistry of 4-bromobiphenyl. J Org Chem 1991, 56: 6072.
25. Photochemistry and Photobiology of Nucleic Acids, Vol. 1. Wang, S.Y. (Ed.). Academic Press: New York 1976.
26. Voelk, E. The photolytic action of 3-amino-6-iodoacridine with nucleic acids. Ph.D. Thesis, The Ohio State University 1991.
27. Chen, T., Platz, M.S. Unpublished research at the Ohio State University.
28. Rosenberg, J.M., Seeman, N.C., Day, R.O., Rich, A. RNA double-helica1 fragments at atomic resolution II: The crystal structure of sodium guanylyl-3′,5′-cytidine nonahydrate. J Mol Biol 1976, 104: 145.
29. Microbial Genetics. Freifelder, D. (Ed.). Jones and Bartlett Publishers, Inc.: Boston MA.
30. Vitiligo and Psoralens. El Mofty, A.M. (Ed.). Pergamon Press: Oxford.
31. Fitzpatrick, T.B., Pathak, M.A. Research and development of oral psoralen and long wave radiation photochemotherapy: 2000 B.C.-1982 A.D. In: Photobiologic, Toxicologic, and Pharmacologic Aspects of Psoralen (NIH Publication #84-2692). Natl Cancer Inst Monogr 1984, 66: 25.
32. Midden, W.R. Chemical mechanisms of the bioeffects of furocoumarins: The role of reactions with proteins, lipids, and other cellular components. In: Psoralen DNA Photobiology. Gasparro, F.P. (Ed.). CRC Press: Boca Raton 1988, 16.
33. Ben-Hur, E. Photosensitized virus decontamination of blood. The Spectrum 1994, 11-13.
34. Saroj, R., Kasturi, C., Grayzar, J. et al. Dramatic improvements in viral inactivation with brominated psoralens, naphthalenes and anthracenes. Photochem Photobiol 1993, 58: 59.
35. Song, P.S., Tapley, K.J. Jr. Photochemistry and photobiology of psoralens. Photochem Photobiol 1979,29: 1177.
36. Aebischer, J.N., Platz, M S. Unpublished research at the Ohio State University.
37. Rai, S. Viral inactivation using DNA intercalators and dyes for sterilization of blood products. Ph.D. Thesis. The Ohio State University 1992.
38. Kagan, S., Platz, M.S. Unpublished research at the Ohio State University.
39. Oroskar, A.A., Gasparro, F.P., Peak, M.J. Relaxation of supercoiled DNA by aminomethyl trimethylpsoralen and UV photons: Action spectrum. Photochem Photobiol 1993, 57: 648.
40. Goodrich, R.P., Yerram, N.B., Tay-Goodrich, B.H. et al. Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives. Proc Natl Acad Sci USA 1994, 91: 5552.
41. Goodrich, R.P., Sowemimo-Coker, S.O., Anthony, R.P. et al. Inactivation of human immunodeficiency virus type 1 (HIV-1) and cytomegalovirus (CMV) in human platelet concentrates (PC) using a novel psoralen derivative (CP-38) and long wavelength ultraviolet light (UVA). Transfusion 1994, 34: S168.
42. Sowemimo-Coker, S., Yerram, N., Park, S.C. et al. Inactivation of human immunodeficiency virus type 1 (HIV-1) in human platelet concentrates (PC) using a new psoralen derivative (CP-38) and ultraviolet A light (UVA). Vox Sang 1994, 67: 36.
43. Yerram, N.R., Park, S.C., Goodrich, T., Crandall, S., Sowemimo-Coker, S.O., Goodrich, R.P. Application of standard platelet storage containers in ultraviolet-A (UVA) mediated photoinactivation of viruses in platelet concentrates. Transfusion 1994, 34: S167.
44. Yerram, N.R., Sowemimo-Coker, S., Park, S.C. et al. Evaluation of standard platelet storage containers for use in photoinactivation of viruses using ultraviolet-A (UVA) radiation. Vox Sang 1994, 67: 162.
45. Margolis-Nunno, H., Williams, B., Rywkin, S., Geactinov, N., Horowitz, B. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers. Transfusion 1992, 32: 51.
46. Wasserman, H.H., Berdahl, D.R. The photooxidation of 8-methoxypsoralen. Photochem Photobiol 1982, 35: 565.
47. Caffieri, S., Favretto, D. UV-A photolysis of khellin: Products and reaction mechanism. J Org Chem 1993, 58: 7059.
48. Goodrich, R.P., Yerram, N.R., Crandall, S.L., Sowemimo-Coker, S.O. In vivo survival of platelets subjected to virus inactivation protocols using psoralen and coumarin photosensitizers. Blood 1995, 86: 354.
49. Rhodes, J., Chen, H., Hall, S.R. et al. Therapeuticpotentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature 1995, 377: 71.
50. Marley, K.A., Larson, R.A. A new photoproduct from furocoumarin photolysis in dilute aqueous solution: 5-Formyl-6-hydroxybenzofuran. Photochem Photobiol 1994, 59: 503.
51. Goodrich, R.P., Sowemimo-Coker, S.O., Park, S.C. In vivo and in vitro acute toxicity and genotoxicity of psoralen and coumarin based photosensitizers. Blood 1995, 86: 857.
52. Sowemimo-Coker, S.O., Park, S., Yerram, N.R., Crandall, S., Goodrich, R.P. Inactivation of human immunodeficiency virus type 1 (HIV-1) and mutagenicity testing in human platelet concentrates (PC) after treatment with a coumarin based compound and long wavelength ultraviolet A light (UVA). Blood 1995, 86: 861.